Catherine C. Turkel - 12 Oct 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Issuer symbol
LEXX
Transactions as of
12 Oct 2022
Net transactions value
$0
Form type
4
Filing time
13 Oct 2022, 17:16:36 UTC
Previous filing
06 Sep 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +1,600 +47% $0.000000 5,000 12 Oct 2022 Common Shares 1,600 $1.96 Direct
holding LEXX Stock Options 3,400 12 Oct 2022 Common Shares 3,400 $3.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.